The business software maker's fiscal second-quarter revenue fell short of
The design software company's fiscal fourth-quarter profit and revenue beat analysts' forecasts.
Bond yields fell, which hurts banks' ability to charge more lucrative interest on mortgages and other loans.
The maker of high-end shoes and handbags said the CEO of its
The drug developer received regulatory approval for a muscular dystrophy treatment.
The drug developer gave investors an encouraging update on its development of a cancer treatment.
The
Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed., source